Roche Provides Reach For Millennium Rheumatoid Arthritis Test
This article was originally published in The Gray Sheet
Executive Summary
Millennium Pharmaceuticals' three-year partnership with Roche Diagnostics to develop proteomics-based diagnostic products for rheumatoid arthritis complements the firm's existing alliance with Aventis to jointly commercialize therapeutic products for the disease.